Tuberculosis incidence among contacts of active pulmonary tuberculosis

Int J Tuberc Lung Dis. 2009 Feb;13(2):190-5.

Abstract

Background: Treatment of latent tuberculosis (TB) infection (LTBI) in Brazil is recommended only in the case of contacts of pulmonary smear-positive TB patients aged<or=15 years with a tuberculin skin test (TST)>or=10 mm and no previous bacille Calmette-Guérin (BCG) vaccination or with a TST>or=15 mm regardless of previous BCG vaccination.

Objective: To evaluate the 2-year incidence and predictors of TB among contacts who did not meet the Brazilian criteria for LTBI treatment.

Design: Retrospective cohort study. Contacts aged between 12 and 15 years and those aged>or=15 years who did not meet the Brazilian criteria for LTBI treatment were enrolled in the study.

Results: TB incidence was 3.2% (22/667), with an estimated TB rate of 1649 per 100000 population. Risk of TB was greater among the 349 contacts with TST>or=5 mm (5.4%) compared to the 318 contacts with TST<5 mm (0.9%; RR 6.04, 95%CI 1.7-20.6).

Conclusion: The high incidence of TB among contacts who did not meet the Brazilian criteria for LTBI treatment strongly suggests that these criteria should be reviewed. Furthermore, even among BCG-vaccinated contacts, TST induration>or=5 mm was the only variable that predicted the development of TB disease within 2years.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antitubercular Agents / therapeutic use
  • Brazil
  • Carrier State / diagnosis
  • Carrier State / epidemiology*
  • Cohort Studies
  • Disease Transmission, Infectious / prevention & control
  • Disease Transmission, Infectious / statistics & numerical data*
  • Female
  • Humans
  • Incidence
  • Isoniazid / therapeutic use
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Predictive Value of Tests
  • Pyrazinamide / therapeutic use
  • Retrospective Studies
  • Rifampin / therapeutic use
  • Risk
  • Tuberculin Test
  • Tuberculosis, Pulmonary / diagnosis
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / epidemiology*
  • Tuberculosis, Pulmonary / transmission*
  • Young Adult

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Isoniazid
  • Rifampin